Company Overviews & Analysis Listed Alphabetically "X"
In this section you will find information products, including market research reports, on companies starting with the letter X.
Your filters
clear all
None selected
| Xeikon NV: Wright Investors' Service Research Report (WRT21326) A textual analysis of the financial results for Xeikon NV compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up... | May 2013 | £38€45$59 |
| Xpec Entertainment Incorporation: Wright Investors' Service Research Report (WRT32725) A textual analysis of the financial results for Xpec Entertainment Incorporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and... | May 2013 | £38€45$59 |
| XDx, Inc. - Product Pipeline Analysis, 2013 Update (GDA40734) Summary XDx, Inc. (XDx) is a biotechnology company. The company develops molecular diagnostic assays that translate a patient's immune status into clinically actionable information. It discovers gene expression testing for the... | May 2013 | £480€569$750 |
| XEPTAGEN SpA - Product Pipeline Analysis, 2013 Update (GDA40735) Summary Xeptagen SpA (Xeptagen) is a healthcare company. The company discovers novel molecular markers to produce diagnostic kits for the early detection, monitoring, and screening of cancerous cells. Its products include... | May 2013 | £480€569$750 |
| Xhibit Corp: Wright Investors' Service Research Report (WRT36953) A textual analysis of the financial results for Xhibit Corp compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up... | May 2013 | £38€45$59 |
| Xoma Corporation: Wright Investors' Service Research Report (WRT35631) A textual analysis of the financial results for Xoma Corporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up... | May 2013 | £38€45$59 |
| Xoom Corp: Wright Investors' Service Research Report (WRT36813) A textual analysis of the financial results for Xoom Corp compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up... | May 2013 | £38€45$59 |
| Xinjiang Tianhong Papermaking, Ltd.: Wright Investors' Service Research Report (WRT19637) A textual analysis of the financial results for Xinjiang Tianhong Papermaking, Ltd. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses... | May 2013 | £38€45$59 |
| Xinjiang Youhao (Group) Company Limited: Wright Investors' Service Research Report (WRT20986) A textual analysis of the financial results for Xinjiang Youhao (Group) Company Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio... | May 2013 | £38€45$59 |
| Xinjiang Urban Construction (Group) Company Limited: Wright Investors' Service Research Report (WRT20985) A textual analysis of the financial results for Xinjiang Urban Construction (Group) Company Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive... | May 2013 | £38€45$59 |
| XL Group plc (XL) - Financial and Strategic SWOT Analysis Review (GDA16492) Summary XL Group plc (XL Group), formerly XL Capital Ltd, is a global insurance and reinsurance provider. The group provides a range of insurance and reinsurance coverage to commercial, industrial and... | May 2013 | £80€95$125 |
| XenoPort, Inc. (XNPT) - Financial and Strategic SWOT Analysis Review (GDA15950) Summary XenoPort, Inc. (XenoPort) is a bio-pharmaceutical company with focus on the development and commercialization of internally discovered product candidates for the treatment of neurological disorders. The company develops prodrugs which... | May 2013 | £80€95$125 |
| Xcite Energy Limited (XEL) - Financial and Strategic SWOT Analysis Review (GDA29770) Summary Xcite Energy Limited (Xcite Energy) is a heavy oil appraisal and development company. Xcite Energy carries out its operations through its wholly owned subsidiary, Xcite Energy Resources Limited (XER). The... | May 2013 | £80€95$125 |
| XL Group Plc (XL) : Company Profile and SWOT Analysis (WMI18131) Synopsis World Market Intelligence's 'XL Group Plc (XL) : Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains a company... | May 2013 | £77€91$120 |
| Xoft Inc. - Medical Equipment - Deals and Alliances Profile (GDA10874) Summary Xoft Inc. (Xoft) is a medical device company. The company develops brachytherapy systems using its miniaturized X-ray tube technology to apply a therapeutic dose of isotope-free radiation to a tumor... | Apr 2013 | £160€190$250 |
| Xceed Molecular - Medical Equipment - Deals and Alliances Profile (GDA35880) Summary Xceed Molecular (Xceed) is a molecular diagnostic company, engaged in the design, development and distribution of diagnostic test kits, reagents and instruments for the in-vitro diagnostic markets. In addition, the... | Apr 2013 | £160€190$250 |
| XDx, Inc. - Medical Equipment - Deals and Alliances Profile (GDA25466) Summary XDx, Inc. (XDx) is a biotechnology company. The company develops molecular diagnostic assays that translate a patient's immune status into clinically actionable information. It discovers gene expression testing for the... | Apr 2013 | £160€190$250 |
| Xerius Bioscience AG:Wright Investors' Service Research Report (WRT33670) A textual analysis of the financial results for Xerius Bioscience AG compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and... | Apr 2013 | £38€45$59 |
| Xchanging Solutions Limited:Wright Investors' Service Research Report (WRT27117) A textual analysis of the financial results for Xchanging Solutions Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and... | Apr 2013 | £38€45$59 |
| Xpress Group Limited:Wright Investors' Service Research Report (WRT14117) A textual analysis of the financial results for Xpress Group Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and... | Apr 2013 | £38€45$59 |
| Xebio Co., Ltd.:Wright Investors' Service Research Report (WRT09329) A textual analysis of the financial results for Xebio Co., Ltd. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and... | Apr 2013 | £38€45$59 |
| Xiezhong International Holdings Ltd:Wright Investors' Service Research Report (WRT36538) A textual analysis of the financial results for Xiezhong International Holdings Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses... | Apr 2013 | £38€45$59 |
| Xinjiang Tianye Co., Ltd.:Wright Investors' Service Research Report (WRT20557) A textual analysis of the financial results for Xinjiang Tianye Co., Ltd. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses... | Apr 2013 | £38€45$59 |
| Xiamen XGMA Machinery Company Limited:Wright Investors' Service Research Report (WRT21607) A textual analysis of the financial results for Xiamen XGMA Machinery Company Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio... | Apr 2013 | £38€45$59 |
| Xinlong Holding (Group) Company Limited:Wright Investors' Service Research Report (WRT19291) A textual analysis of the financial results for Xinlong Holding (Group) Company Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio... | Apr 2013 | £38€45$59 |
previous

